Objective: To determine risk and protective factors for mild cognitive impairment (MCI) among persons 85 years and older.
invited to participate in person or by telephone. This study is limited to participants who were aged 85-89 years at enrollment (October 1, 2004 , or March 1, 2008 and were cognitively normal at the baseline evaluation.
In-person evaluation. The evaluation consisted of 3 components. A nurse or study coordinator interviewed the participant to assess memory and administered the Clinical Dementia Rating scale 6 and the Functional Activities Questionnaire (FAQ) 7 to an informant to assess participant functioning. A physician evaluation included the Short Test of Mental Status 8 and a neurologic examination. A psychometrist performed neuropsychological testing using 9 tests to assess performance in memory, executive function, language, and visuospatial skills. The raw test scores were transformed into age-adjusted scores using normative data. 9 Domain scores were computed by summing and scaling the age-adjusted test scores within domains to allow comparisons across domains. 9 Diagnostic criteria. MCI was diagnosed per published criteriacognitive concern, impairment in 1 or more of the 4 cognitive domains, essentially normal functional activities, and absence of dementia 3,4,10 -and classified as amnestic (aMCI) or nonamnestic MCI (naMCI). Dementia was diagnosed according to DSM-IV criteria. 11 Participants were considered cognitively normal if they performed within the normative range and did not meet MCI or dementia criteria. 3, 4, 10 Exposures and covariates. Demographic information, weight, height, and timed gait speed (m/s) were determined at the interview. A stroke history was obtained by the physician and validated in the medical record. Depressive symptoms in the previous month were assessed using the Neuropsychiatric Inventory Questionnaire (NPI-Q). 12 Participants completed self-administered questionnaires on engagement in exercise and in cognitive activities in midlife (age 50 years) and late life (1 year prior to the evaluation). Medical comorbidities and date of onset of these conditions were abstracted from participant medical records using the REP medical records-linkage system. 5, 13 APOE genotyping was performed. Chronic disease burden was assessed from a weighted Charlson Comorbidity Index (CCI) score 14 using ICD-9 codes (table e-1 on the Neurology ® Web site at Neurology.org). This score takes into account disease severity, and was developed to assess impact of disease burden on health outcomes. Vascular disease burden was assessed as the total number of vascular diseases and related conditions: type 2 diabetes mellitus, hypertension, dyslipidemia, coronary artery disease, congestive heart failure, atrial fibrillation, peripheral vascular disease, stroke, and obesity.
Longitudinal follow-up. Follow-up was performed at 15month intervals. To avoid potential bias in making a diagnosis, clinical and cognitive findings from previous evaluations were not considered. Participants who declined the in-person evaluation at follow-up were invited to participate by a telephone interview that included the Telephone Interview of Cognitive Status-Modified, 15 the Clinical Dementia Rating scale, 6 and the NPI-Q. 12 Standard protocol approvals, registrations, and patient consent. This study was approved by the Institutional Review Boards of the Mayo Clinic and Olmsted Medical Center. Written informed consent was obtained from all participants.
Statistical analyses. The date of MCI onset was assigned at the midpoint between the last assessment as cognitively normal and the first-ever assessment as MCI; participants who developed dementia without an MCI diagnosis were included. Persons who were lost to follow-up or died were censored at their last evaluation. We estimated follow-up time from baseline to onset of MCI, date of censoring, or last follow-up. We investigated bivariate associations of risk and protective factors with MCI using Cox proportional hazards models adjusted for sex and education, with age as a time variable. Exposures and covariates were APOE e4 allele (any e4 vs no e4), type 2 diabetes, hypertension, dyslipidemia, body mass index, engagement in exercise and cognitively stimulating activities, high-sensitivity C-reactive protein, and smoking (current and former vs never). When possible, we characterized variables as present in midlife (#65 years) or late life (.65 years); or in midlife only, late life only, or both. We performed stratified analyses by MCI subtypes and by sex. In multivariable models, we included variables that were significantly associated with MCI.
In sensitivity analyses, we estimated the annualized percent change (slope) in FAQ score, memory, and executive function z scores for each participant, and computed and compared the average slope for participants grouped by performance of activities in midlife or late life. Associations were considered significant at p values ,0.05, using SAS version 9.3 (SAS Institute, Cary, NC).
RESULTS
Of the 301 participants who were cognitively normal at enrollment, 256 (85.0%; median age, 87.3 years, 62.1% [n 5 159] women) had $1 follow-up evaluation (table 1). Women had a lower frequency of an APOE e4 allele, were older, had a lower median CCI score, and had a lower vascular disease burden than men. Participants with no follow-up were younger (median age, 86.6 years; p 5 0.03) but did not differ from those with follow-up regarding sex, education, APOE e4 allele, Table 1 Characteristics of study participants at baseline, overall and by sex diabetes, hypertension, gait speed, engagement in exercise, or cognitive activities.
Predictors of incident MCI. There were 121 incident MCI events over a median 4.1 (interquartile range 2.6, 6.1) years of follow-up. MCI risk was associated with an APOE e4 allele, hypertension (midlife and late life), depressive symptoms, and increased with increasing CCI score and vascular disease burden (table 2) . The risk was reduced in participants engaging in artistic, craft, and social activities in both midlife and late life, and computer use in late life. Estimates from the multivariable models were essentially unchanged (data are not presented). When stratified by midlife or late life, the risk of MCI was reduced in participants engaging in artistic, social, and group activities, and reading newspapers in midlife; and with artistic and craft activities, and computer use in late life (table e-2).
Predictors of MCI subtypes. In bivariate models, depressive symptoms were associated with an increased risk of aMCI; social activity in both midlife and late life was associated with reduced risk (table 3) . The point estimates from the multivariable model were essentially unchanged, but the associations were marginally significant (data not presented). Significant predictors of naMCI were an APOE e4 allele, diabetes (midlife and late life), hypertension (midlife and late life), increasing CCI score, and increasing vascular disease burden. The risk of naMCI was reduced with computer use in late life and with increasing gait speed. Estimates from the multivariable were similar; the association with education was significant (hazard ratio [HR] 0.74, p 5 0.004). The associations of APOE genotype with naMCI persisted even with the e3e3 genotype as the reference category (table e-3).
Predictors of MCI by sex. In men, MCI was associated with depressive symptoms and higher CCI scores in bivariate models (table 4) ; estimates changed little in multivariate models (data not shown). In women, MCI risk factors were hypertension and diabetes in midlife and late life, and increasing vascular disease burden. The risk was reduced with engaging in crafts and artistic activities in midlife and late life, and computer use in late life in bivariate models, and changed little in multivariate models (data not shown).
Sensitivity analyses. Participants who never engaged in cognitively stimulating activities had greater average declines in FAQ score, memory, and executive function z scores compared to those who did; these differences did not reach statistical significance due to small sample sizes. For example, for computer use, decline in FAQ score was 20.790 for never vs 20.105 for computer use in late life only; decline in memory was A strength of our study was that it distinguished the impact of factors in midlife, late life, or both on MCI risk. For factors associated with reduced risk, this allowed us to disentangle the potential effects of reverse causation, where the outcome precedes and causes the exposure. Engaging in beneficial lifestyle activities in midlife only, or initiating them in late life, did not consistently confer benefit. Persons who performed certain activities only in midlife may have ceased to perform them in late life due to incipient cognitive impairment. Alternatively, those who performed activities in late life may have done so because they still could. Others may have discerned cognitive decline and initiated activities in late life as an effort to curb progression, suggesting reverse causation.
Our findings suggest that the burden of chronic conditions or vascular diseases may predict MCI in persons aged 85 years and older. Multiple chronic conditions may contribute to longstanding pathologic insults to the brain through cerebrovascular disease and related mechanisms, including endothelial dysfunction, inflammation, and oxidative damage, which lead to neuronal death, synaptic dysfunction, and cognitive impairment. 16 Certain established risk factors for cognitive impairment (e.g., hyperlipidemia, smoking, C-reactive protein, obesity) may not have predicted MCI because of survival bias, or because the cumulative burden of disease may have greater impact on risk than a single disease at very old ages. The association of APOE e4 with aMCI is consistent with a neurodegenerative etiology. The association with naMCI, however, was unexpected, but may relate to the adverse vascular effects of APOE e2 and e4. [17] [18] [19] APOE e2 and e4 alleles have been reported to increase atherogenic lipoproteins and accelerate atherogenesis. 20 These effects are consistent with the hypothesized vascular etiology for naMCI, and consistent with our findings in table e-3. Thus, although the small numbers suggest a spurious association, the present findings may be real. However, they remain to be validated in a larger population-based cohort of oldest old.
The association of midlife hypertension with MCI underscores the need for aggressive prevention at younger ages. Targeted education of the general population regarding the association of vascular disease with MCI risk may promote lifestyle changes and treatment compliance. Effectively monitoring and managing persons with hypertension particularly in midlife may also prevent adverse cardiovascular outcomes that increase MCI risk. 21, 22 Interestingly, our findings suggest that nonpharmacologic preventive strategies may reduce naMCI risk in the oldest old. Higher education may reduce risk by increasing cognitive reserve, which in turn may delay clinical expression of symptoms or counteract vascular assaults on the brain. 23, 24 The reduced risk with computer use and with artistic or crafts activities suggest that these activities should be promoted throughout life. These activities may also increase cognitive reserve, maintain neuronal function, stimulate neural growth, and recruit alternate neural pathways to maintain cognitive function. 25 By contrast, failure to observe protective factors for aMCI suggests that oldest old participants at risk for aMCI possibly have greater pathology resulting from both neurodegenerative and vascular effects that may be less amenable to nonpharmacologic interventions. Although we did not observe significant associations with exercise, the reduced HR for persons who exercised in late life suggests a potential benefit for MCI (0.55 for MCI, 0.66 for aMCI; table 2 footnote).
In sex-stratified analyses, MCI risk increased with increasing burden of chronic disease in men and with increasing burden of vascular disease in women. This difference raises the hypothesis that oldest old men may be sicker than women, and this multifactorial morbidity may contribute to MCI. The higher vascular disease burden in women, as observed with diabetes and hypertension, may increase MCI risk. A lower vascular disease burden in men may be due to the earlier onset of these conditions in men, leading to earlier mortality (survival bias). Finally, the protective effects of artistic and craft activities and computer use in women suggest opportunities for exploring comparable interventions in men.
Some of our findings are consistent with previous studies among persons 90 years and older. In particular, the beneficial effects of cognitively stimulating activities on cognition are consistent with previous findings. 25, 26 Absence of a protective effect of education on aMCI risk in the present study is consistent with the rapid cognitive decline observed in highly educated late-stage aMCI patients from a memory clinic. 27 The association of increasing gait speed with decreased risk of naMCI is in keeping with the documented increase in the odds ratio of dementia with decreasing gait speed in persons in the 901 study 28 and with MCI in the MCSA cohort. 29 In the MCSA, depressive symptoms were associated with an increased risk of aMCI. 30 This is consistent with the putative role of aMCI as being a prodromal AD stage. Similarly, another study reported an association of late-life depressive symptoms with increased risk of AD, and suggested that recurrent depression was more likely to be etiologically associated with vascular dementia. 31 Together, these findings suggest that depressive symptoms may be in the causal pathway or may be a marker for incipient aMCI or AD. Certain of our findings, however, are inconsistent with prior studies among persons aged 90 years and older. Although the association of APOE e4 with incident MCI has not been reported in the oldest old, the impact of the e4 allele on dementia risk is thought to be minimal or absent in the oldest old. 32 In the 901 study, APOE e4 carrier status (vs e3e3) was associated with dementia in cross-sectional but not in prospective analyses. 33 The frequency of an APOE e4 allele was only 8.1% in the incident cohort, compared to 18.8% in the present study. Thus, earlier mortality associated with APOE e4 may preclude detection of significant associations with cognitive risk in studies among persons age 90 years and older. With the e3e3 genotype as the reference group, the association of the e4 allele with MCI persisted (table e-3). Hypertension in midlife was associated with naMCI risk, but a similar association was not observed in a 901 study cohort 2 perhaps because of survival bias, cross-sectional design, different study endpoints, or to failure to take the age at onset of hypertension into account.
One potential limitation of our study is that cognitive activities and exercise were assessed only at baseline. Thus, we were unable to determine the effects of discontinuation of these activities during follow-up. Second, there may be residual reverse causation; declining cognition could have promoted engagement in cognitive activities in some participants. 34 However, declining cognitive activities have been shown to predict cognitive impairment, but not the reverse. 26 Given the old age of participants, there is a potential for recall bias. We previously assessed the reliability of the physical activity questionnaire in 87 persons who completed the questionnaire at 2 time periods. The internal consistency was moderate to good, a Cronbach a of 0.71, and the testretest Spearman rank correlation coefficient was 0.50 for moderate exercise. 35 Engagement in cognitive activities in midlife/late life may simply be a marker for healthy cognition, with a noncausal association with MCI. Finally, our findings are based on a cohort with a primarily Northern European ancestry.
Strengths of our study include the populationbased, prospective design, the comprehensive evaluation of participants, and the assignment of cognitive status by consensus both at enrollment and followup. The ascertainment of chronic diseases and medical conditions from the medical records allowed us to reliably determine the presence and onset of risk factors in midlife and late life. The ascertainment of cognitively stimulating activities and exercise in a population-based cohort of cognitively normal 85to 89-year-olds allowed us obviate the potential impact of reverse causation. Blinding the study evaluators to previous clinical assessments and cognitive diagnosis contributed to unbiased ascertainment of cognitive status during follow-up.
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R.O. Roberts had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data Comment: Too much of a good thing may still be good for your brain Approximately 5 million Americans live with mild cognitive impairment (MCI) and Alzheimer disease (AD). Age adds a layer of complexity to disease management not present with younger adults, as older adults have a greater likelihood of multiple chronic conditions that can diminish their capacity to function independently. Chronic disease burden increases risk of MCI, while certain lifestyle factors may reduce MCI risk. 1 This implies that preventive strategies for MCI may need to begin in midlife and persist throughout late life.
While we cannot cure MCI or AD, there is increasing evidence that disease risk may be modifiable. Besides age and family history (not modifiable), the strongest risk factors in the literature include hypertension, diabetes, cardiovascular disease, hypercholesterolemia, obesity, low levels of mental and physical activities, decreased social engagement, and poor dietary patterns. [1] [2] [3] The present study 1 focused on 256 cognitively normal participants over a median of 4.1 years, of whom 121 (47%) developed MCI. Using medical records and patient-reported history, the investigators were able to tease out medical conditions that increased the risk of MCI (including hypertension, vascular disease, depression, and increasing numbers of chronic medical conditions). More importantly, they were able to discern protective effects from midlife and late-life activities, including arts and crafts, social engagement, and using a computer. While self-reports of how much artistic, social, or physical activities one does 30 years prior could be contaminated with reporting biases, these findings are consistent with other clinicopathologic studies 2,3 that clearly demonstrate the beneficial effects of cognitively and socially stimulating activities on the rate of cognitive decline and the level of Alzheimer pathology.
Long ago, "an apple a day keeps the doctor away" was a common expression, suggesting that eating well could improve health. Perhaps today the expression should expand to include painting an apple, going to the store with a friend to buy an apple, and using an Apple product.
